Hormone Replacement Therapy (HRT) sometimes called estrogent replacement therapy or ERT, refers to a woman taking supplements of hormones such as estrogen alone or estrogen with another hormone called progesterone (progestin in its synthetic form). HRT replaces hormones that a woman’s body should be making or used to make.
The 2007 Guidelines for Preventing Cardiovascular Disease in Women -- published today in a special women's health issue of Circulation: Journal of the American Heart Association -- also include new directions for using aspirin, hormone therapy and vitamin and mineral supplements in heart disease and stroke prevention in women.
Health care professionals should focus on women's lifetime heart disease risk, not just short-term risk, according to updated American Heart Association guidelines.
Drug giant Wyeth has been ordered by a court in Philadelphia to pay $1 million in compensation to a woman who developed breast cancer after taking the hormone replacement therapy (HRT) Prempro.
The results in 2002 of a large U.S. study on hormone replacement therapy (HRT) in many respects left women confused and alarmed about the treatment for the menopause.
Researchers in the U.S. are suggesting that hormone replacement therapy (HRT) may possibly exacerbate hearing deficits in women who take it following the menopause.
University of Rochester researchers, who have been investigating new therapies for hot flashes for several years, report in the July Obstetrics and Gynecology journal that the seizure drug gabapentin is as effective as estrogen
Researchers at the University of Manchester are testing a secret herb in a bid to stop the severe hot flushes that besiege breast cancer patients on hormone treatment.
For the last few years, women have heard conflicting reports about the risks and benefits of hormone replacement therapy (HRT). A new study that analyzes many trials together concludes that HRT can reduce heart attacks by about one-third in women under age 60 but has mixed results for older women.
Recent research presented at EBCC-5 from the million women study found that taking Hormone Replacement Therapy (HRT) increased the risk of some types of breast cancer, but not others.
Healthy Women who go on to develop breast cancer tend to have less symmetrical breasts than those women who do not develop the disease, researchers at the University of Liverpool have found.
The controversy over Hormone Replacement Therapy (HRT) rages on. Over 40 million American women are within menopause age, and in five years the numbers will increase to over 60 million.
According to experts hormone fluctuations resulting from life cycle changes are a factor in higher rates of asthma, more frequent emergency department visits, and higher hospital admission rates in women than in men.
Med Services Europe GmbH, a "Virtual European Headquarters" for Pharmaceutical and Medical Manufacturers, announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals.
A British expert says that although exercise is important for reducing the risk of osteoporosis and heart disease in post-menopausal women, too much exercise in pre-menopausal women may actually increase the risks.
A new study to be published in the journal CANCER in October has found that many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed.
Women battling to deal with the miserable effects of the menopause, will be even more confused by the release of a new Australian study, which says that a woman's risk of developing breast cancer after taking hormone replacement therapy (HRT) might be lower than previously thought.
In somewhat depressing news for women battling that often miserable phase in their lives, the menopause, it appears that more than half of women who start taking hormone replacement therapy to relieve the discomfort, can expect to see a dramatic resurgence of those symptoms, when they discontinue the therapy.
Research shows that short-term hormone replacement therapy (HRT) is appropriate for peri- and postmenopausal women.
Melbourne researchers are urging women on Hormone Replacement Therapy (HRT) to be extra vigilant about having regular two-yearly mammograms.
Women treated for breast cancer who are considering taking Hormone Replacement Therapy (HRT) should be cautious when using published research to inform their decision. An article published today in the journal Breast Cancer Research reveals that qualitative studies on the recurrence of breast cancer in breast cancer survivors undergoing HRT are unreliable.